Back to results
US 2022/0088148 A1Published application
A pharmaceutical composition comprising insulin and trigonal glucagon/glp-1/gip receptor agonist
AssigneeHanmi Pharm. Co., Ltd.
InventorsJong Suk LEE, Jung Kuk KIM, Sang Don LEE, Jong-Soo LEE, Sang Yun KIM
Life of this patent
Estimating the term…
Abstract
A composition including insulin and a triple agonist having activity with respect to all of a glucagon receptor, GLP-1 receptor, and GIP receptor is disclosed. A composite preparation including the composition is also disclosed.
Claims43
A composition comprising:
- (i) insulin;
- and
- (ii) an isolated peptide having activity to glucagon, glucagon-like peptide-1 (GLP-1), and glucose-dependent insulinotropic polypeptide (GIP) receptors.
38-39. (canceled)
-60. (canceled)
Dependencies are inferred from the claim text.